Abstract
Background
Pregnant women participated in multifaceted case management (MCM) to prevent Fetal Alcohol Spectrum Disorders (FASD).
Methods
Women recruited from antenatal clinics for a longitudinal child development study were screened for alcohol use. Forty-four pregnant women were defined as high-risk drinkers on the Alcohol Use Disorder Identification Test (AUDIT) by an AUDIT score ≥8 and participated in 18 months of MCM to facilitate reduction or cessation of alcohol consumption. Forty-one women completed MCM. Fifty-five equally high-risk women who received standard antenatal care comprised the comparison/control group. Development in offspring was evaluated by a blinded interdisciplinary team of examiners through 5 years of age.
Results
At five years of age, more children (34%) of MCM participating women did not meet the criteria for FASD vs. non-MCM offspring (22%). Furthermore, a statistically significant (p = .01) lower proportion of MCM offspring (24%) was diagnosed with fetal alcohol syndrome (FAS) compared to controls (49%). Children of MCM participants had significantly (p < .05) better physical outcomes: lower total dysmorphology scores, larger head circumferences, longer palpebral fissures, and higher midfacial measurements. Neurodevelopment results showed mixed outcomes. While Bayley developmental scores indicated that MCM offspring were performing significantly worse on most domains through 18 months, group scores equalized and were not significantly different on Kaufman Assessment Battery neurobehavioral measures by five years. Regression analyses indicated that offspring of women who received standard antenatal care were associated with significantly more negative outcomes than MCM offspring: a diagnosis of FAS (OR = 3.2; 95% CI: 1.093–9.081), microcephaly (OR = 5.3; 95% CI: 2.1–13.5), head circumference ≤10th centile (OR = 4.3; 95%CI: 1.8–10.4), and short palpebral fissures (OR = 2.5; 95% CI: 1.0–5.8).
Conclusion
At age five, proportionally fewer children of MCM participants qualified for a diagnosis of FAS, and proportionally more had physical outcomes indicating better prenatal brain development. Neurobehavioral indicators were not significantly different from controls by age five.
KEY MESSAGES
Multifaceted Case Management (MCM) was designed and employed for 18 months during the prenatal and immediate postpartum period to successfully meet multiple needs of women who had proven to be very high risk for birthing children with fetal alcohol spectrum disorders (FASD).
Offspring of the women who participated in MCM were followed up through age five years and were found to have significantly better physical outcomes on multiple variables associated with fetal alcohol syndrome (FAS) and FASD, such as larger head circumferences and fewer minor anomalies, than those children born to equally at-risk women not receiving MCM.
Fewer children of women receiving MCM were diagnosed with FASD than the offspring of equally-at-risk controls, and significantly (p = .01) fewer MCM offspring had FAS, the most severe FASD diagnosis.
Keywords: Fetal alcohol spectrum disorders (FASD), fetal alcohol syndrome (FAS), prenatal alcohol exposure (PAE), multifaceted case management (MCM), prevention, intervention, prenatal alcohol use, maternal risk for FASD
Introduction
The prevalence of fetal alcohol syndrome (FAS) and fetal alcohol spectrum disorders (FASD) in some communities in the Western Cape Province (WCP) of South Africa (ZA) is the highest documented in the published literature anywhere to date [1]. FASD is the umbrella term for a continuum of adverse effects due to prenatal alcohol exposure. Individuals who fall within the FASD continuum present with physical, neurocognitive, and behavioral impairments including, but not limited to, growth deficiencies, minor physical anomalies, and deficiencies in at least one cognitive or behavioral domain. The adverse effects of prenatal alcohol exposure are persistent across the lifespan [2,3]. In the WCP, FASD affected 17–31% of first grade students in the general populations of five communities [4–7]. The prevalence of FASD in general populations has been conservatively estimated to be 1–5% in the United States, 2–3% in Ontario, Canada, 2–4% in Italy, 1.8% in Manchester, United Kingdom, and 4–6% in Croatia [8–14]. FASD prevalence has also been reported as high elsewhere in ZA and to vary by ethnicity, socioeconomic status, and community of residence [15–17].
Preventing FASD
Prenatal alcohol exposure (PAE) presents the most serious overall risk to the fetus of any commonly used recreational substance. The National Institute of Alcohol Abuse and Alcoholism (NIAAA) defines binge drinking as a pattern of drinking that results in a blood alcohol concentration of 0.08% or greater; in females this equates to 4 or more drinks in about 2 h [18]. However, previous research on risk to fetus has indicated that binge drinking three or more standard drinks per occasion poses a significant risk factor for FASD or other negative physical or neurobehavioral outcomes in many populations [1,19–23]. Thirty-seven to 60% of women in European countries, and over 10% of women in the United States (US) reported alcohol use during pregnancy [24]. Binge drinking in any and all trimesters is particularly harmful [25]. One-third of Australian women reported prenatal drinking, and 18.5% from varying social strata reported first trimester binge drinking, particularly on special occasions [26]. Globally, estimates indicate that 9.8% of women drink, and up to 14% binge drink prenatally [1,27]. Prenatal drinking was reported as 40–50% in population-based studies of the WCP of ZA, and prenatal binge drinking was more common [28,29] than the 7% in province-wide surveys [30]. In pursuing FASD research in SA, we have been ethically compelled to provide preventive services for as many heavy drinking women as possible with available resources.
Screening and interventions
For this intervention, Multifaceted Case Management (MCM) employed principles of Motivational Interviewing (MI) and Community-Reinforcement Approach (CRA) in a program that taught basic coping skills for life stresses and techniques for reducing alcohol use [31–36]. The goal was to improve child outcomes, document key developmental outcomes empirically, and prevent FASD by supporting pregnant women through empathic care via MCM.
Alcohol screening and brief interventions during pregnancy have been recommended for education and prevention of alcohol-exposed pregnancies [37–39]. Recommended preventive education themes include using positive, carefully-worded questions and conversations to explore drinking habits, building trust with patients, and providing rationale and encouragement for alcohol-free pregnancies [40–43]. Brief, women-focused prenatal interventions that provide basic knowledge of fetal development and FASD, assistance in navigating the healthcare system, education on domestic partner communications/relationships, and enhanced motivation for an alcohol-free pregnancy are also recommended [44–47]. While 81% of US adults report being asked about their drinking by a healthcare provider, only 38% were asked about binge drinking; and of those who binge drink, 42% were advised of harmful drinking levels, and 80% were not advised to reduce drinking [38]. Among pregnant women in Maryland, 19% were not screened for alcohol consumption and 30% indicated that their healthcare provider did not counsel them about the adverse effects of prenatal alcohol exposure [48]. In the National Survey of Family Growth 2011–2013, the CDC found that only 54% of women who reported consuming alcohol 3 months before pregnancy received information on the effects of alcohol on fetal development from their healthcare provider [49]. Overall, there is a pressing need for preventive interventions, such as case management and similar programs for prenatal alcohol use that are not commonly practiced [50].
It is often necessary to adapt general screening and prevention modalities and therapeutic strategies to local cultures. Motivational Interviewing (MI) [33] is a therapeutic change modality implemented to reduce problem drinking for individuals, including pregnant women [51] and specific cultural groups, such as American Indians [52–54]. Furthermore, Rendall-Mkosi et al. [55] reported that a five-session randomized, controlled trial of MI intervention for ZA women of childbearing age significantly reduced alcohol-exposure in pregnancy by 51% compared to 28% in non-participants.
Underpinnings and practices of multifaceted case management to prevent FASD
Our team has combined the above recommended intervention themes, standard practices, and techniques from MI and the Community Reinforcement Approach (CRA) into MCM for the prevention of FASD within our research programs in ZA. MI uses five core principles to elicit and manage positive changes in alcohol use: (1) express empathy for the client; (2) develop discrepancy in the client’s understanding of current behavior and the need to accomplish important goals; (3) avoid argumentation; (4) roll with client resistance; and (5) support client self-efficacy [33]. CRA provides techniques and guidelines for therapists/managers to recruit, motivate, and guide a client’s family and significant others to elicit positive change in drinking and social behaviors [56].
Previous evaluations of the MCM FASD prevention
In a previous evaluation of this MCM approach that specifically targeted change in drinking practices, we reported that pregnant women reduced their drinking significantly on: total drinks on weekends 6 months after MCM initiation and had significantly lower estimated peak blood alcohol concentrations after 6 and 18 months [57]. However, reductions in drinking during pregnancy were often followed by postpartum relapses to heavy weekend drinking 18 months later. Scores on the Alcohol Use Disorders Identification Test (AUDIT) indicated that problematic drinking decreased significantly during pregnancy, and remained lower 6–12 months after MCM initiation [58].
The hypothesis of this evaluation: a focus on child outcomes
While several measures in the previous evaluation of MCM provided evidence of a reduction in prenatal drinking, this study focused on the empirical documentation of specific child outcomes. The hypothesis in this study was whether reduced prenatal drinking resulted in improved indicators of child development and fewer cases of FASD among offspring of women receiving MCM. To our knowledge, measurement of multiple, actual child outcomes (both physical and neurobehavioral) has not been reported before in evaluating an FAS prevention program.
Methods
Screening and criteria for inclusion in multifaceted case management
Project research staff recruited study participants from community health care clinics in two WCP regions separated by a mountain range (Figure 1). All pregnant women registering for antenatal care [mean = 4.7 months gestation (SD = 1.8 months)] in both regions were invited to participate in first-level screening for a longitudinal study of child development. The screening included the Self-Administered Questionnaire (SAQ) [59], AUDIT [60], and questions on previously-identified risk factors from previous WCP studies [20,61].
While women were recruited for the development study in both regions, MCM could only be offered in one of the two regions. MCM was provided to women, prenatally and postpartum, for 18 months. The growth and development of offspring were studied 60 months postpartum. Comprehensive, structured maternal risk interviews were conducted with participating MCM women at intake, 3, 6, 9 12, and 18 months after MCM intake (Figure 1).
Criteria for MCM entrance included: (1) self-reported drinking of eight or more drinks per week during the index pregnancy; or (2) one binge of three or more drinks reported any day of the week on the SAQ; or (3) scores of ≥8 on the AUDIT (possible 40 points) at screening.
Training and implementation of MCM
MCM was implemented by bilingual (Afrikaans and English) project officers formally trained as social workers or nurses. Study protocols and skills utilized in MCM were gained from two separate training workshops, each consisting of two weeks of intensive, specialized instruction from experts in social work, MI, CRA, FASD, and intervention. Professional mentoring and supervision were provided throughout the study by a bi-lingual lead trainer, a native of the WCP with a doctorate in social work and decades of professional experience. The training was implemented to ensure the fidelity of implementation of MCM in the local culture of this predominantly mixed-race, ‘Cape Coloured’ population.
Following recruitment into the study, project officers made visits at least once a month during the remainder of pregnancy with each MCM participant, commencing two weeks after screening. Visits every two weeks were made if circumstances of higher risk warranted. After the children were born, visits were less frequent, and the focus switched to the maintenance of abstinence or alcohol use reductions to facilitate alcohol-free breastfeeding and options for voluntary birth control. Postpartum MCM also addressed themes, such as coping with postpartum depression, family planning, and infant care, delivered empathically.
Nutritional supplementation for low BMI women
Low maternal weight and body mass index (BMI) were identified previously as important distal risk factors for FASD in these communities [20,62,63]. At intake, the left upper arm circumference was measured to determine the need for nutritional supplements to improve pregnancy outcomes for low BMI participants. Women with an upper arm circumference of ≤23cm (n = 22, 50%) were provided supplementation powder for mixing with water for daily consumption during the index pregnancy.
The left upper arm circumference and the women’s weight were measured at each formal interview during the MCM process. These were measured four times in pregnancy and once post-partum.
MCM investigation was part of the longitudinal study of development
Recruitment into MCM was concurrent with the recruitment of a large cohort (n = 199) to test the efficacy of Bayley Scales of Infant Development (BSID-III) [64] for early life detection of children with FASD [65]. All children born from these pregnancies were monitored for growth and development with the same protocols. All participants were informed at the recruitment interview at the first antenatal visit that drinking during pregnancy was harmful to the fetus, and all participants were encouraged to stop drinking or reduce drinking during pregnancy and encouraged to use contraception once the child is born. Throughout the course of the MCM process, participants were provided information on the harmful effects of alcohol on the development of the fetus and given additional information on fetal and child development, the role of the father in pregnancy, contraception, supportive messages, information on resources in the community, and social support to assist abstinence or reduced alcohol use and other MCM support at each visit. Women in the control group received only standard prenatal care and information from clinic personnel.
Assessing and diagnosing the offspring
In-person examinations and assessments of physical growth and dysmorphology of the children born to the participating women were undertaken at six weeks and 9, 18, 42, and 60 to 72 months by research staff. Final examinations were administered by pediatric dysmorphologists and consisted of measuring height, weight, occipitofrontal (head) circumference (OFC), facial anthropometry, and the assessment of 30 minor anomalies of the face, heart, and hands [66,67].
Developmental assessments with the BSID-III were performed at 6 weeks, 9, 18, and 42 months to assess milestones in cognitive, language, motor, and social-emotional domains. At 60–70 months, the Kaufman Assessment Battery for Children (KABC-II) [68] was administered by psychometrists to provide a mental processing index. The KABC-II is considered a culturally fair test that has been used in previous ZA research [69,70]. Age-adjusted percentile rank scores (range: 1–99) are presented for both BSID-III and KABC. All MCM and non-MCM women completed an in-person, final MCM maternal risk interview at 42 or 60 months postpartum. The interviews covered demographic, socioeconomic, childbearing history, and alcohol, tobacco, and other drug use variables before pregnancy and each trimester. All participants were compensated for their time with credit vouchers.
Final diagnoses for children were assigned in structured, multidisciplinary case conferences in either 2015 or 2017. Results from physical, neurobehavioral, and maternal risk assessments were reviewed by team members who had performed the assessments. All clinicians and interviewers had been blinded to prior information on each child and mother during clinical exams, testing, and interviews. MCM participation status was also blinded throughout the exams, testing, and diagnostic processes, for the overall focus of the parent study was the longitudinal assessment of the larger developmental cohort for child growth and development [65]. Final diagnoses were assigned by the pediatric dysmorphologists using the revised Institute of Medicine (IOM) guidelines [67,71]. FASD diagnoses included: (1) fetal alcohol syndrome (FAS); (2) partial fetal alcohol syndrome (PFAS); (3) alcohol-related neurodevelopmental disorder (ARND); or (4) alcohol-related birth defects (ARBD).
Sample
All maternal/child dyads participated in the developmental study from the initial prenatal visit until the children reached a minimum age of 60 months (Figure 2). Forty-four women who met heavy drinking criteria and lived in the region where MCM could be offered were enrolled in MCM, but three women dropped out and were excluded from the analysis. Among the other 155 women and children, 19 dyads had insufficient data to rule on an FASD diagnosis when final diagnoses were made. Of the remaining 136 women, 35 (25.7%) reported abstaining from alcohol, 46 (33.8%) were drinkers with AUDIT scores ≤7, and 55 (40.4%) met the criteria for hazardous drinking. Therefore, the final sample in this MCM evaluation is 96 dyads, 41 of whom were in MCM for 18 months during pregnancy and postpartum, and 55 dyads not participating in MCM who met the criteria for heavy drinking for the index pregnancy.
Data analysis
Data analysis was completed in SPSS 26.0 [72]. t-Tests (for continuous variables) and chi-square tests (for categorical variables) compared maternal demographics and alcohol consumption. The children’s physical and cognitive outcomes at 60 months for the neurobehavioral testing and up to 80 months for age-adjusted physical traits are presented. Given the fact that this evaluation of an FASD intervention via a comparison of global child outcomes is the first of its kind, alpha significance levels were set a p < .05. Additionally, in interpreting Table 3 results, we also provided Bonferroni-adjusted values. Post-hoc, Z-tests compared the proportion of children with specific diagnoses within the FASD continuum. Unadjusted binary logistic regression evaluated the association (p ≤ .05) of MCM participation on the likelihood of offspring having specific FASD diagnoses (e.g. FAS vs. control), small head circumference (≤3rd centile vs. not and ≤10th centile vs. not), and short palpebral fissures (≤3rd centile vs. not) for maternal participants and non-participants and for women who reported drinking in the 3rd trimester. The medical geneticists/dysmorphologists are trained and highly experienced in the differential diagnosis of FASD as one of a range of birth anomalies, and an FASD diagnosis is made only after excluding other birth defects and anomalies common to other phenotypes which are caused by other known genetic or teratogenic influences. Therefore, statistical controls for exposures other than tobacco were not needed. Tobacco has been shown to exert a relatively minor influence on the diagnosis of FASD in this population when compared to the influence of alcohol [4,6], and it is also controlled and assessed separately in the regression analysis.
Table 3.
At 60 months | Alcohol-exposed without MCM (n = 53) | Alcohol-exposed with MCM (n = 38) | p |
---|---|---|---|
Mean (SD) | Mean (SD) | ||
Height centile | 20.2 (25.0) | 21.8 (23.5) | .757 |
Weight centile | 17.3 (26.9) | 17.4 (21.3) | .989 |
OFC centilea | 11.9 (20.6) | 21.3 (21.7) | .039 |
OFC ≤ 3rd centile | 62.3 | 23.7 | <.001b |
OFC ≤ 10th centile | 73.6 | 39.5 | .001b |
Inner canthal distance (ICD) centile | 55.5 (18.8) | 65.8 (16.7) | .008 |
Inner pupillary distance (IPD) centile | 43.8 (22.7) | 58.1 (22.7) | .004 |
Palpebral fissure length (PFL) centile | 11.8 (11.6) | 22.2 (17.9) | .001b |
Smooth philtrum (% Yes)a | 41.5 | 44.7 | .759 |
Narrow vermilion (% Yes)a | 54.7 | 42.1 | .235 |
Hypoplastic midface (% Yes) | 66.0 | 55.3 | .297 |
Maxillary arc (in cm) | 22.5 (1.1) | 23.0 (.8) | .024 |
Mandibular arc (in cm) | 23.7 (1.3) | 24.1 (1.0) | .150 |
Strabismus (% Yes) | 9.4 | 7.9 | .798 |
Epicanthal folds (% Yes) | 56.6 | 63.2 | .530 |
Prognathism (% Yes) | 0.0 | 0.0 | – |
Camptodactyly (% Yes) | 9.4 | 0.0 | .051 |
Number of minor anomalies | 7.7 (3.2) | 6.2 (2.7) | .018 |
Total dysmorphology score | 12.9 (5.3) | 10.5 (5.4) | .035 |
OFC: occipitofrontal circumference.
aScore of 4 or 5 on the South African lip/philtrum guide [67].
bVariables are significant at the Bonferroni-adjusted values for this table at p < .0026.
Results
MCM contact with participants
The mean number of MCM contacts with participants was 10.5 (SD = ±4.7), and total face-to-face contact time averaged 7.6 h per participant (SD = ±2.6 h). Final status assessment visits and data collection with all women (MCM participants and non-participants) occurred 18 months post-recruitment.
Maternal risk factors of MCM women and controls
Proximal and distal maternal risk factors presented in Table 1 indicate that both groups of women were generally high risk, for AUDIT and T-ACE (Tolerance, Annoyance, Cut Down, and Eye Opener) scores were very high for both. However, women who participated in MCM were historically the highest risk drinkers as measured by the AUDIT (19.7 vs. 15.1, p = .001) and both groups were equally high risk on the T-ACE (3.5 vs. 4.0, p = .061). The participants in MCM were entered into the study at the time of the first antenatal visit which was generally in the 2nd trimester (mean = 4.7 months). The usual number of drinks per drinking day (DDD) was significantly higher (p ≤ .05) in the non-MCM participant women in the 1st trimester (10.1 vs. 6.2) and 2nd trimester (9.9 vs. 6.2). Frequency of drinking, however, was significantly higher in the MCM group in the 1st trimester: 92.3% of MCM participants and 71.6% non-participants usually drank 1–7 days every week. In the 2nd and 3rd trimesters, the difference in frequency was not significantly different. There were no significant differences in breastfeeding measures, including the percentage drinking alcohol during the breastfeeding period (66.0 vs. 64.7%). Of the distal risk factors, only parity at intake was significant; the parity of non-MCM participants was higher (3.0 and 2.3), indicating a slightly greater risk for FASD. While a higher AUDIT score for the MCM participants indicated historically more problematic drinking and MCM participants reported greater frequency in the 1st trimester, the non-MCM participants had a significantly higher DDD in the 1st and 2nd trimesters. Overall, the known risk factors were equal among the groups; both groups were high-risk.
Table 1.
Alcohol-exposed without MCM (n = 55) |
Alcohol-exposed with MCM (n = 41) |
|||||
---|---|---|---|---|---|---|
N | Mean (SD) | N | Mean (SD) | p | ||
Proximal risk factors | ||||||
T-ACE at intake | 55 | 3.5 (1.3) | 40 | 4.0 (1.1) | .061 | |
AUDIT score at intake | 55 | 15.1 (5.5) | 41 | 19.7 (7.5) | .001 | |
Estimated Month Enrolled in MCM | – | – | 41 | 4.7 (1.8) | – | |
Drank in 1st trimester (% Yes)a | 48/50 | 96.0 | 36/38 | 94.7 | .778 | |
Usual number of drinks per drinking day—1st trimester | 49 | 9.7 (11.0) | 38 | 5.9 (3.9) | .046 | |
Usual number of drinks per drinking day—1st trimesterb | 49 | 10.1 (11.1) | 38 | 6.2 (3.7) | .047 | |
Usual frequency of drinking—1st trimester | ||||||
Every day or almost every day | 5 | 9.4 | 0 | 0.0 | ||
3–4 times per week | 14 | 26.4 | 19 | 48.7 | ||
1–2 times per week | 19 | 35.8 | 17 | 43.6 | ||
1–3 times per month | 8 | 15.1 | 0 | 0.0 | ||
1–2 times per 3 months | 2 | 3.8 | 0 | 0.0 | ||
Unknown frequency | 3 | 5.7 | 1 | 2.6 | ||
Did not drink | 2 | 3.8 | 2 | 0.0 | .020 | |
Drank in 2nd trimester (% Yes)a | 37/50 | 74.0 | 33/38 | 86.8 | .139 | |
Usual number of drinks per drinking day—2nd trimester | 46 | 7.1 (9.1) | 38 | 5.4 (4.5) | .284 | |
Usual number of drinks per drinking day—2nd trimesterb | 46 | 9.9 (9.3) | 38 | 6.2 (4.2) | .040 | |
Usual frequency of drinking—2nd trimester | ||||||
Every day or almost every day | 4 | 7.5 | 0 | 0.0 | ||
3–4 times per week | 10 | 18.9 | 14 | 35.9 | ||
1–2 times per week | 16 | 30.2 | 17 | 43.6 | ||
1–3 times per month | 4 | 7.5 | 2 | 5.1 | ||
1–2 times per 3 months | 1 | 1.9 | 0 | 0.0 | ||
Unknown frequency | 5 | 9.4 | 1 | 2.6 | ||
Did not drink | 13 | 24.5 | 5 | 12.8 | .098 | |
Drank in 3rd trimester (% Yes)a | 24/49 | 49.0 | 20/38 | 52.6 | .735 | |
Usual number of drinks per drinking day—3rd trimester | 49 | 5.8 (11.7) | 37 | 2.6 (4.1) | .117 | |
Usual number of drinks per drinking day—3rd trimesterb | 49 | 11.8 (14.6) | 37 | 5.0 (4.5) | .059 | |
Usual frequency of drinking—3rd trimester | ||||||
Every day or almost every day | 4 | 7.7 | 0 | 0.0 | ||
3–4 times per week | 6 | 11.5 | 5 | 12.8 | ||
1–2 times per week | 9 | 17.3 | 13 | 33.3 | ||
1–3 times per month | 3 | 5.8 | 1 | 2.6 | ||
1–2 times per 3 months | 2 | 3.8 | 0 | 0.0 | ||
Unknown frequency | 3 | 5.8 | 2 | 5.1 | ||
Did not drink | 25 | 48.1 | 18 | 46.2 | .281 | |
Breastfed (% Yes)c | 50/52 | 96.2 | 35/39 | 89.7 | .223 | |
Duration of breastfeeding (months)d | 50 | 18.2 (16.0) | 35 | 24.5 (18.0) | .097 | |
Drank alcohol in breastfeeding period (% Yes)d | 33/50 | 66.0 | 22/34 | 64.7 | .903 | |
Distal maternal risk factors | ||||||
Gravidity at intake | 55 | 3.1 (1.8) | 41 | 2.5 (1.3) | .119 | |
Parity at intake | 55 | 3.0 (1.7) | 41 | 2.3 (1.3) | .028 | |
Estimated infant gestational age at delivery (weeks) | 49 | 37.4 (2.8) | 35 | 39.2 (1.8) | .002 | |
Height at interview (cm) | 45 | 155.3 (6.6) | 38 | 155.9 (6.7) | .692 | |
Weight at interview (kg) | 45 | 55.5 (14.2) | 38 | 59.2 (19.4) | .316 | |
Occipitofrontal circumference at interview (cm) | 45 | 54.3 (2.2) | 38 | 55.3 (2.7) | .078 | |
Left upper arm circumference at interview (cm) | 45 | 25.1 (4.3) | 37 | 26.2 (4.8) | .311 | |
BMI at interview | 45 | 23.0 (5.1) | 38 | 24.2 (6.9) | .367 | |
Age at interview (yrs) | 48 | 32.9 (8.0) | 38 | 30.1 (7.2) | .086 |
aSpecific alcohol consumption information by trimester was known for n = 50 for women without MCM and n = 38 for women with MCM.
bAmong drinkers only.
cBreastfeeding information was known for n = 52 for women without MCM and n = 39 for women with MCM.
dAmong those who breastfed.
Comparison of MCM and Non-MCM women with and without nutritional supplementation
Tables A1–A5 in the Appendix summarize a comparison of the 22 MCM participants who received nutritional supplementation and the 19 MCM participants who did not. Women who qualified for supplementation were significantly (p < .02) lighter (68.0 vs. 50.4 kg), had a lower BMI (27.2 vs. 21.1 kg/m2), had a smaller upper arm circumference (28.3 vs. 23.9 cm) and head circumference (56.6 vs. 54.0 cm), and were younger (32.7 vs. 27.4 years) (Table A1). There was no significant difference among groups in any of the child physical outcomes at 60 months (Table A2) and one significant difference: motor development at six weeks and 42 months was lower for offspring of the supplemented women (Table A3). Considering KABC results, the offspring of supplemented women performed significantly worse on the KABC sequential short-term memory and number recall (Table A4). Finally (Table A5), there was no significant difference in final diagnosis: the proportion of FAS, PFAS, ARND, ARBD, and Not FASD were similar for both groups. Nutritional supplementation, if it had an effect, may have been to equalize the outcomes by assisting the lighter women with adequate nutrition for similar development as the offspring of the heavier, lower risk, women.
Table 5.
Alcohol-exposed without MCM | Alcohol-exposed with MCM | p | |
---|---|---|---|
Mean (SD) | Mean (SD) | ||
Cognitive percentile rank at 6 weeksa | 57.0 (31.4) | 20.2 (15.4) | <.001 |
Cognitive percentile rank at 9 monthsb | 49.6 (30.2) | 47.9 (26.5) | .811 |
Cognitive percentile rank at 18 monthsc | 42.0 (26.2) | 18.4 (14.1) | <.001 |
Cognitive percentile rank at 42 monthsd | 31.3 (14.2) | 24.0 (14.6) | .301 |
Language percentile rank at 6 weeksa | 36.2 (28.1) | 14.4 (12.4) | <.001 |
Language percentile rank at 9 monthsb | 32.2 (28.3) | 15.6 (22.1) | .012 |
Language percentile rank at 18 monthsc | 28.0 (17.9) | 19.8 (14.4) | .057 |
Language percentile rank at 42 monthsd | 31.5 (15.2) | 17.8 (12.5) | .056 |
Motor percentile rank at 6 weeksa | 69.2 (26.0) | 38.2 (20.9) | <.001 |
Motor percentile rank at 9 monthsb | 39.8 (30.6) | 25.9 (17.1) | .037 |
Motor percentile rank at 18 monthsc | 39.6 (29.8) | 28.9 (19.9) | .114 |
Motor percentile rank at 42 monthsd | 68.6 (21.9) | 46.0 (24.7) | .057 |
Social/emotional percentile rank at 6 weeksa | 46.7 (26.7) | 42.4 (24.2) | .527 |
Social/emotional percentile rank at 9 monthsb | 52.2 (32.6) | 35.8 (30.1) | .039 |
Social/emotional percentile rank at 18 monthsc | 54.7 (31.2) | 30.4 (22.6) | .001 |
Social/emotional percentile rank at 42 monthsd | 50.2 (20.3) | 33.8 (19.2) | .093 |
aN = 43 for alcohol-exposed with MCM; N = 22 for alcohol-exposed with MCM.
bN = 43 for alcohol-exposed with MCM; N = 27 for alcohol-exposed with MCM.
cN = 42 for alcohol-exposed with MCM; N = 25 for alcohol-exposed with MCM.
dN = 10 for alcohol-exposed with MCM; N = 8 for alcohol-exposed with MCM.
Final diagnoses at five years of age: MCM vs. non-MCM
A significantly lower proportion of the children of MCM participants was diagnosed with FAS than the non-MCM group (24.4 vs. 49.1%, p = .01) (Table 2). More of the children with PFAS (19.5 vs. 14.5%) and ARND (19.5 vs. 14.5%) were born to MCM-participating women than the non-MCM group. One child with ARBD was born to a woman in MCM. Finally, a non-significant, higher proportion of the children without an FASD diagnosis were born to MCM-participating women (34.1 vs. 21.8%). The chi-square value of the FASD diagnoses distribution was not statistically significant [χ2(4) = 7.073, p = .132].
Table 2.
Alcohol-exposed without MCM (n = 55) N (%) |
Alcohol-exposed with MCM (n = 41) N (%) |
p-Value from z-test of proportions | |
---|---|---|---|
FAS | 27 (49.1) | 10 (24.4) | .0102 |
PFAS | 8 (14.5) | 8 (19.5) | .5261 |
ARND | 8 (14.5) | 8 (19.5) | .5261 |
ARBD | 0 (0.0) | 1 (2.4) | .3213 |
Not FASD | 12 (21.8) | 14 (34.1) | .1892 |
χ2(4) = 7.073, p = .132.
Physical characteristics of index children at five years of age by participation in MCM
In Table 3, nine FAS-linked physical trait variables of the index offspring were significantly different between the maternal MCM groups at p < .05. All represent more positive outcomes for the MCM offspring group. Head (occipitofrontal) circumference (OFC) centile was larger for the MCM group (21.3 vs. 11.9 cm) and fewer of the MCM offspring had OFC measurements that were ≤3rd and ≤10th centile. Four midface measurements were larger for the MCM offspring: inner canthal distance (ICD), interpupillary distance (IPD), palpebral fissure length (PFL), and maxillary arc measurements. There was no significant difference among groups with two of the cardinal facial features of FAS: smooth philtrum and narrow vermilion of the upper lip, both of which are associated with first trimester drinking. Finally, at p < .05 significantly fewer minor anomalies were identified (7.7 vs. 6.2) in the MCM offspring, and lower mean total dysmorphology scores (12.9 vs. 10.5) were characteristic of the offspring of women with MCM. If Bonferroni-adjustment values of significance were applied to Table 3, only three variables were significant: OFC ≤10th centile, OFC ≤3rd centile, and PFL centile.
Table 4 presents physical trait data for specific FASD diagnoses (FAS, PFAS, and ARND) for children of maternal groups at five years of age. Of the 41 women completing MCM, 27 (65.9%) of their offspring received specific FASD diagnoses, and 14 (34.1%) did not. Children of MCM participants with FAS had a significantly higher average OFC, and fewer had true microcephaly (≤3rd centile) than non-MCM children. MCM participant offspring with PFAS were significantly more likely to have a smooth philtrum. Approaching significance (.05 ≤ p ≤ .10) were larger heads, larger ICD, and larger PFL. Finally, for the ARND group, OFC, ICD, and IPD were all significantly larger for the MCM participant offspring. Indicators of better brain development were present in the MCM offspring within each specific diagnosis category.
Table 4.
(A) Children with FAS | |||
---|---|---|---|
At 60 months | Alcohol-exposed without MCMa (n = 26) | Alcohol-exposed with MCMa (n = 9) | p |
Mean (SD) | Mean (SD) | ||
OFC centile | 1.4 (1.0) | 2.7 (2.5) | .036 |
OFC ≤ 3rd centile | 96.2 | 66.7 | .017 |
Inner canthal distance (ICD) centile | 56.6 (17.4) | 61.6 (19.9) | .483 |
Inner pupillary distance (IPD) centile | 37.3 (19.7) | 36.3 (12.4) | .887 |
Palpebral fissure length (PFL) centile | 5.9 (5.9) | 5.9 (7.9) | .999 |
Smooth philtrum (% Yes) | 73.1 | 77.8 | .781 |
Narrow vermilion (% Yes) | 69.2 | 77.8 | .625 |
Number of minor anomalies | 9.6 (2.7) | 9.2 (1.6) | .713 |
Total dysmorphology score | 16.8 (3.4) | 16.8 (3.2) | .986 |
(B) Children with PFAS | |||
Alcohol-exposed without MCM (n = 7) | Alcohol-exposed with MCM (n = 8) | ||
At 60 months |
Mean (SD) |
Mean (SD) |
p
|
OFC centile | 12.4 (10.9) | 36.3 (31.3) | .079 |
Inner canthal distance (ICD) centile | 55.9 (12.4) | 68.0 (10.0) | .056 |
Inner pupillary distance (IPD) centile | 39.0 (12.1) | 54.1 (24.8) | .167 |
Palpebral fissure length (PFL) centile | 6.0 (6.8) | 19.6 (17.0) | .070 |
Smooth philtrum (% Yes) | 28.6 | 87.5 | .020 |
Narrow vermilion (% Yes) | 71.4 | 62.5 | .714 |
Number of minor anomalies | 7.6 (1.1) | 7.3 (.7) | .515 |
Total dysmorphology score | 12.9 (1.8) | 12.1 (2.4) | .514 |
(C) Children with ARND | |||
Alcohol-exposed without MCM (n = 8) | Alcohol-exposed with MCM (n = 8) | ||
At 60 months |
Mean (SD) |
Mean (SD) |
p
|
OFC centile | 4.5 (4.3) | 19.3 (13.3) | .010 |
OFC ≤ 3rd centile | 50.0 | 25.0 | .302 |
OFC ≤ 10th centile | 87.5 | 37.5 | .039 |
Inner canthal distance (ICD) centile | 46.3 (22.8) | 70.8 (12.7) | .019 |
Inner pupillary distance (IPD) centile | 44.1 (23.5) | 72.4 (15.8) | .014 |
Palpebral fissure length (PFL) centile | 17.0 (12.5) | 21.8 (13.8) | .482 |
Smooth philtrum (% Yes) | 0.0 | 25.0 | .131 |
Narrow vermilion (% Yes) | 37.5 | 0.0 | .055 |
Number of minor anomalies | 6.8 (2.6) | 4.9 (2.8) | .187 |
Total dysmorphology score | 10.5 (3.1) | 8.4 (5.3) | .341 |
aAll mothers in both categories had AUDIT scores > 8 and were considered hazardous drinkers.
Neurobehavioral traits of children compared by participation in MCM and age
Neurobehavioral traits on the BSID-III are presented in Table 5 for children at 6 weeks to 42 months. Offspring of the MCM group scored lower on all domains (cognitive, language, motor, and social/emotional) up to 42 months. The MCM offspring were significantly lower in specific categories of functioning on most all domains (cognitive, language, motor, and social emotional) at 18 months and younger, but not at 42 months.
The KABC results (Table 6) indicated that by age 5, the offspring groups were virtually identical in their performance in all domains: global, short- and long-term memory, and visual processing. No average percentile ranks were above 37, indicating poor performance for both groups. Only long-term storage of information and retrieval percentile rank approached significance, and this p-value may be an artifact of multiple comparisons.
Table 6.
Alcohol-exposed without MCM (n = 42) | Alcohol-exposed with MCMa (n = 32) | p | |
---|---|---|---|
Mean (SD) | Mean (SD) | ||
Global percentile rank | 10.9 (16.2) | 9.2 (12.5) | .574 |
Sequential short term memory percentile rank | 23.6 (20.8) | 20.6 (20.2) | .474 |
Number recall percentile rank | 36.3 (28.6) | 35.5 (29.1) | .263 |
Word order recall percentile rank | 18.6 (13.8) | 14.8 (14.8) | .993 |
Simultaneous visual processing percentile rank | 8.0 (15.6) | 5.0 (7.9) | .865 |
Triangles percentile rank | 12.2 (16.4) | 13.5 (16.7) | .208 |
Pattern reasoning percentile rank | 20.3 (22.2) | 12.0 (15.6) | .795 |
Conceptual thinking percentile rank | 8.8 (11.6) | 9.9 (18.2) | .880 |
Long term storage and retrieval percentile rank | 25.0 (21.6) | 25.1 (19.5) | .077 |
Atlantis percentile rank | 36.6 (27.6) | 33.4 (24.8) | .494 |
Rebus percentile rank | 18.9 (18.8) | 22.9 (23.3) | .428 |
aDue to end of funding for the grant at the intervention site, nine of the offspring of women participating in MCM were not tested and the neurobehavioral component of their diagnosis were based on their Bayley scores.
Logistic regression analysis
Regression analysis compares the association of MCM to selected child developmental outcomes (Table 7). Children born to alcohol-using women without MCM (standard care), were 3.15 times more likely to have FAS (p = .034, 95% CI = 1.09–9.08) than MCM offspring. OFC in the offspring of MCM participants was also associated with a positive outcome. The odds of a head circumference ≤3rd centile (p < .001, 95% CI = 2.09–13.49), and of an OFC ≤10th centile (p = .001, 95% CI = 1.75–10.42) were 5.32 and 4.27 greater for the non-MCM offspring. Finally, not receiving MCM was associated with a decrease in the length of eye openings (palpebral fissure length—PFL) over that of children of women in MCM (OR = 2.46, p = .039, 95% CI = 1.05–5.78). Smaller head circumference and PFL are considered direct measures of poor brain growth and development.
Table 7.
B | SE | Sig | Odds ratio | 95% CI |
||
---|---|---|---|---|---|---|
Lower | Upper | |||||
Predicting FAS (n = 63) | ||||||
Not in MCM vs. in MCM (reference) | 1.147 | .540 | .034 | 3.15 | 1.093 | 9.081 |
Constant | −.336 | .414 | .416 | .714 | – | – |
Predicting OFC ≤3rd centile (n = 91) | ||||||
Not in MCM vs. in MCM (reference) | 1.671 | .475 | <.001 | 5.317 | 2.094 | 13.496 |
Constant | −1.170 | .382 | .002 | .310 | – | – |
Predicting OFC ≤10th centile (n = 91) | ||||||
Not in MCM vs. in MCM (reference) | 1.452 | .455 | .001 | 4.271 | 1.750 | 10.424 |
Constant | −.427 | .332 | .198 | .652 | – | – |
Predicting PFL ≤3rd centile (n = 91) | ||||||
Not in MCM vs. in MCM (reference) | .900 | .436 | .039 | 2.461 | 1.047 | 5.782 |
Constant | −.318 | .329 | .332 | .727 | – | – |
Another comparison in Table 8 assessed the difference in the offspring of the two groups who reported 3rd trimester drinking. In three of the comparisons, FAS diagnosis, OFC ≤ 3rd, and OFC ≤10th, the offspring of non-participants were (respectively OR = 6.0, 4.9, and 6.5) more likely to have these less desirable traits.
Table 8.
B | SE | Sig | Odds ratio | 95% CI |
||
---|---|---|---|---|---|---|
Lower | Upper | |||||
Predicting FAS (n = 29) | ||||||
Not in MCM vs. in MCM (reference) | 1.792 | .876 | .041 | 6.00 | 1.079 | 33.378 |
Constant | −.182 | .606 | .763 | .833 | – | – |
Predicting OFC ≤3rd centile (n = 42) | ||||||
Not in MCM vs. in MCM (reference) | 1.600 | .670 | .017 | 4.952 | 1.332 | 18.414 |
Constant | −.773 | .494 | .117 | .462 | – | – |
Predicting OFC ≤10th centile (n = 42) | ||||||
Not in MCM vs. in MCM (reference) | 1.877 | .720 | .009 | 6.531 | 1.592 | 26.788 |
Constant | −.318 | .465 | .493 | .727 | – | – |
Predicting PFL ≤3rd centile (n = 42) | ||||||
Not in MCM vs. in MCM (reference) | .116 | .836 | .890 | 1.123 | .218 | 5.777 |
Constant | −1.674 | .629 | .008 | .188 | – | – |
Discussion
Binge drinking is normative and common on weekends among women of childbearing age in the two communities engaged in this study [20,28]. The population of the two study communities was ∼50,000 predominantly mixed-race, ‘Coloured’ individuals in each. The social, cultural, and economic conditions are similar in the two sub-regions, and drinking frequently continues through much of the first trimester for a majority of the women who are drinkers. Many women drink throughout the second trimester, and some throughout the entire pregnancy [4,6]. There are few outlets for recreation for the workers on the farms, orchards, vineyards and small industries, and group drinking on Friday and Saturday night is a major and commonly accepted mode of relaxation and recreation. The result is many alcohol-exposed pregnancies and the highest known rates of FASD recorded in the world to date, rates of 28–31% among active case ascertainment, first grade students in population-bases studies [4,6,27,73].
When the first studies were begun on the epidemiology of FAS in one of these two communities in 1997, it became obvious that the impact of the socio-economic conditions on the families, women, and mothers of the population had to be addressed to reduce the rate of binge drinking and the resultant high rates of FASD. The first comprehensive studies of maternal risk for FASD in these communities indicated the need for a multifaceted approach to address the educational and support needs of the women at the highest risk of having a child with FASD. The MCM approach was the impetus for developing and implementing the prevention of FASD and the evaluation in this manuscript. Furthermore, to our knowledge, this is the first attempt ever to evaluate an approach to FASD prevention by assessing outcome/efficacy via the specific FASD diagnoses and severity of a broad array of both physical and neurobehavioral child developmental traits linked to prenatal alcohol exposure and FASD.
All the women in this evaluation of MCM were recruited from two adjacent regions of the WCP which were of virtually identical socio-economic status and shared a common Western Cape culture. This similarity made group comparison based on MCM participation substantively quite meaningful. The comparisons in this analysis indicated that all the women in these evaluations were hazardous drinkers as indicated by their AUDIT and T-ACE scores at recruitment. Not only were women who participated in MCM identified to be at higher risk on the AUDIT for having a child with FASD, some additional proximal variables of alcohol consumption, such as prevalence and frequency of drinking in the first trimester and throughout pregnancy were significantly higher than the comparison group or there was no significant difference between MCM and non-MCM groups. Furthermore, a comparison of the groups on distal measures of risk for FASD indicated that only one trait, parity, was significant. Therefore, in comparison with other high risk, non-MCM participants, MCM was associated with infants who were physically larger, physically better developed, and had less FASD-specific dysmorphology when compared to alcohol-exposed infants born to women not enrolled in MCM. One question that we cannot answer is if the women who agreed to participate in MCM were self-motivated and ready to change [33,74,75]. If so, were they better candidates for this MCM evaluation than if selected randomly? Since we did not administer a readiness for change evaluation at recruitment or intake, the answer is elusive.
Nutritional enhancement for women with low body mass
One unique aspect of the MCM program was a nutritional enhancement provision for those women who were underweight. Providing daily, multi-vitamin supplements to low BMI women participating in MCM for prenatal consumption may have provided an advantage to MCM women [76] even though the mean weight and BMI were not significantly different at recruitment between the groups. In this population, where a high percentage of women are undernourished in the childbearing ages [77,78], low maternal weight and BMI were associated previously with a higher risk for FASD [5–7,20,62,63,79]. A comparison of child outcomes from supplemented vs. non-supplemented women was summarized in the Appendix (Tables A1–A5). Supplementation did not result in larger children or better neurobehavior relative to the non-supplemented women. One might speculate that without the maternal supplementation, the children of the lower BMI women would have been significantly smaller, but further research is needed on more women who enter prenatal care earlier and receive nutritional supplementation for most of the prenatal period. Nevertheless, findings of no significant difference between the supplemented women and the other MCM women strengthen the case for a fair evaluation of the efficacy of MCM.
Head circumference and neurobehavioral traits of the children in MCM and not in MCM
Although the cognitive and behavioral performance was similar for the groups of children, offspring of women in MCM had significantly larger head circumferences than other alcohol-exposed children without MCM. Head circumference at birth and the early years of life is a measurement that often indicates better prenatal and childhood brain growth and development and potential neurobehavioral development later in life [80,81]. A greater proportion of alcohol-exposed children without MCM had true microcephaly, OFC ≤3rd centile, which is two or more standard deviations below the mean, than did children with MCM. Therefore, the trajectory of cognitive performance of the children without MCM may suffer a greater relative decline than the offspring of MCM participants as the children age [82,83]. Overall, the analyses indicated that a reduced likelihood of a severe diagnosis within the continuum of FASD, especially of FAS, was associated with MCM. The verdict is out on neurobehavioral development, for significant improvement in cognition and behavior was not demonstrated, and all children evaluated had below average performance. Neurobehavioral outcomes should, however, be followed over time, for cognitive performance varies greatly as children age, and recent studies report that better physical indicators at an earlier age bode well for improved cognitive development and function later [80,81]. Before 5 years of age, assessments for children are primarily measures of developmental milestones and not measures of advanced cognitive abilities [84,85], and the children of women participating in MCM performed worse than the offspring of the non-MCM group. Testing at age 8 and above with more sophisticated, age-appropriate tests will be better indicators of the abilities of children from the two groups.
Alcohol consumption and multiple child outcomes from this MCM evaluation
Participation in MCM was associated with a significant reduction in prenatal alcohol consumption in previous evaluations. Mean drinks per weekend, drinking days per week, and AUDIT scores were all reduced significantly six months into MCM [58,61]. Therefore, a significant reduction in antenatal drinking and often during the first year of life via breastmilk when brain growth was vulnerable [86], is likely associated with the major differences in group means, and in the lower odds ratios for adverse outcomes (small head circumference, midface hypoplasia, and a diagnosis of FAS in the MCM offspring). The diagnosis of FAS is, by definition, characterized by the most depressed physical growth and development, more dysmorphology—especially in the brain and midface [66,87,88]. Children with FAS are generally exposed to the most alcohol over the duration of the pregnancy, and OFC and brain development can be affected by alcohol in all trimesters. Two previous publications on this MCM process reported an association between MCM and a reduction in drinking and abstinence [57,58]. Tables 7 and 8 confirmed this association by comparing the women of both groups, and even those who continued to drink in the third trimester. The significant odds ratio indicated 6–6.5 times of increased risk for FAS and microcephaly in children whose mothers did not receive MCM. Overall, a non-statistically significant (p = .189) higher proportion of the offspring from MCM women wasdiagnosed as Not-FASD (34 vs. 22%). Therefore, one possible conclusion is that the lower severity of diagnosis in children from MCM was commonly associated with reductions in alcohol exposure in the later stages of pregnancy. Women in MCM drank less per drinking day, especially in the second and third trimesters, and this was associated with significantly improved OFC and PFL, and significantly fewer were diagnosed as FAS.
Other positive outcomes might have resulted from MCM. General health and social advice and encouragement for better maternal health practices were communicated empathically via MCM and may have contributed to the measured outcomes. In the previous evaluation, women were reported as significantly happier in MCM over time, and this may have helped improve child outcomes [57,58]. Certainly, the general improvement in knowledge of fetal and child development, emotional support, advice on important life choices, and more access to, and the support of, health care professionals provided by MCM project staff was consistent with themes in the prenatal screening and intervention literature [38,43,44]. Many women with hazardous alcohol use in the WCP commonly suffer from multiple problems affecting quality of life: stress, anxiety and depression during pregnancy, and sexual or domestic violence [89]. MCM was well accepted and appreciated by most of the participants from an otherwise underserved population.
FASD policy for prevention in South Africa
The continued high prevalence of FASD in South Africa indicates that there is a need for coordinated prevention efforts on all three levels of prevention and early diagnosis of affected individuals as well as interventions to manage the needs of individuals with FASD [90–93]. Such a comprehensive approach that also takes social determinants of disease into account, calls for specific FASD policies. Despite the extent of the problem with FASD in South Africa, there is no national policy to ensure effective and sustainable services or to create a framework to implement a system for integrated care for individuals with FASD [90,94]. Currently, different government departments address FASD in a generic manner according to their departmental policies and guidelines. This leads to uncoordinated and ineffective services being delivered ‘in silos’ [95].
With the per capita alcohol consumption in South Africa the highest in Africa, it is recommended that FASD policy should also address alcohol policy, specifically the availability of alcohol, maternal alcohol use in pregnancy, and the roles and responsibilities of stakeholders. Other important aspects for FASD policy are that the guiding principles should be holistic, multi-sectoral, human rights based, and culturally sensitive. An FASD policy should also be education-, health-, and community/socially-related [90,92].
Strengths and limitations of this study
This study has several strengths. First, this is the first study, to our knowledge, that has assessed, in detail, the effectiveness of the prenatal intervention to prevent FASD by employing dysmorphology examinations, neurobehavioral testing, and a formal diagnostic evaluation of FASD in the offspring of women in MCM. Direct child outcomes were assessed to evaluate the efficacy of MCM and enhance normal development in children with PAE. Second, the children’s growth and development were followed over time for both groups of at risk, heavy drinking women. There are few FASD prevention studies with controls that assessed child developmental indicators over time [50,81–83,96]. Third, the women in the two groups were well matched on both proximal risk factors (alcohol use in a population that has little co-morbid use of other drugs) and distal risk factors at intake. Fourth, we have done our ethical best and provided a novel intervention, nested and blinded, within a comparative study of the development of children with FASD and controls, to assist as many of those who were the most hazardous drinkers as we could. Obviously, the lack of random assignment causes problems with interpretation of causality, but it was a proper and appropriate intervention for an applied, on the ground public health study. It was a realistic, real world attempt to answer two major priorities for FASD intervention research raised by Hankin et al. [97]: generate a program that reduces barriers to care and determine which programs might be most successful.
There are also limitations to this study. First, the sample size was relatively small and was somewhat limited in statistical power. Second, due to some missed appointments and funding limitations, there were missing data at each time point, and for three dropouts of MCM (6.8%), there were insufficient data for inclusion in this analysis. Third, by design, the study was not randomized. We provided MCM only to the highest risk, heaviest drinking women in one region of our research activities, which made evaluation more challenging. Within our resource limitations, we provided services to as many high-risk women in accordance with our public health research paradigm, to evaluate the impact of MCM. Fourth, while the final diagnosis of the children was performed with the highly-rated, revised IOM diagnostic criteria and processes [73], there was some variance in the age at which all testing and dysmorphology exams were provided. However, since all measures used were applied after appropriate benchmarks had been reached and age-adjusted scores/centiles were utilized, these age/timing problems have been corrected in the analysis. Fifth, the fact that the non-MCM participants were not from the exact same geographic location could be considered a limitation. But given the striking similarities in social, economic, and cultural conditions in these two sub-populations of the WCP, the danger of spurious results is minimized. Finally, a sixth limitation is that no biological markers for alcohol or other drug use were employed in this study. Consequently, these self-reported data may not adequately reflect the actual magnitude of alcohol and other drug use in either group. But, reporting in this population has proven to be accurate in the binary sense in other studies/samples [98].
Conclusion
Multi-faceted Case Management, using elements of Motivational Interviewing, Community Reinforcement Approach, and empathic social work skills can provide significant improvement in child outcomes that are measurable at five years of age and likely in later years.
Acknowledgements
We particularly thank the project officers for their talent, knowledge, persistence, and dedication to the case management process and their care for the participants. We also thank all the women and children for their participation.
APPENDIX.
Table A1.
Alcohol-exposed with MCM not supplemented (n = 19) | Alcohol-exposed with MCM supplemented (n = 22) | p | |
---|---|---|---|
Mean (SD) | Mean (SD) | ||
Alcohol | |||
T-ACE at intake | 4.2 (.9) | 3.8 (1.2) | .312 |
AUDIT score at intake | 20.2 (6.9) | 19.3 (8.1) | .709 |
Estimated Month Enrolled in MCM | 4.9 (2.2) | 4.7 (1.6) | .711 |
Drank in 1st trimester (% Yes)a | 94.7 | 94.7 | – |
Usual number of drinks per drinking day—1st trimester | 5.4 (3.0) | 6.3 (4.6) | .502 |
Usual number of drinks per drinking day—1st trimesterb | 5.7 (2.8) | 6.6 (4.5) | .472 |
Usual frequency of drinking—1st trimester | |||
Every day or almost every day | 0.0 | 0.0 | |
3–4 times per week | 47.4 | 50.0 | |
1–2 times per week | 47.4 | 40.0 | |
1–3 times per month | 0.0 | 0.0 | |
1–2 times per 3 months | 0.0 | 0.0 | |
Unknown frequency | 0.0 | 5.0 | .780 |
Did not drink | 5.3 | 5.0 | |
Drank in 2nd trimester (% Yes)a | 89.5 | 84.2 | .631 |
Usual number of drinks per drinking day—2nd trimester | 5.2 (3.6) | 5.6 (5.3) | .812 |
Usual number of drinks per drinking day—2nd trimesterb | 5.8 (3.2) | 6.6 (5.2) | .603 |
Usual frequency of drinking—2nd trimester | |||
Every day or almost every day | 0.0 | 0.0 | |
3–4 times per week | 36.8 | 35.0 | |
1–2 times per week | 47.4 | 40.0 | |
1–3 times per month | 5.3 | 5.0 | |
1–2 times per 3 months | 0.0 | 0.0 | |
Unknown frequency | 10.5 | 5.0 | .872 |
Did not drink | 0.0 | 15.0 | |
Drank in 3rd trimester (% Yes)a | 52.6 | 52.6 | – |
Usual number of drinks per drinking day—3rd trimester | 2.5 (3.3) | 2.6 (4.9) | .969 |
Usual number of drinks per drinking day—3rd trimesterb | 4.8 (3.0) | 5.2 (6.0) | .868 |
Usual frequency of drinking—3rd trimester | |||
Every day or almost every day | 0.0 | 0.0 | |
3–4 times per week | 15.8 | 10.0 | |
1–2 times per week | 31.6 | 35.0 | |
1–3 times per month | 5.3 | 0.0 | |
1–2 times per 3 months | 0.0 | 0.0 | |
Unknown frequency | 47.4 | 45.0 | |
Did not drink | 0.0 | 10.0 | .516 |
Breastfed (% Yes)c | 89.5 | 90.0 | .957 |
Duration of breastfeeding (months)d | 26.4 (18.9) | 27.2 (17.2) | .374 |
Drank alcohol in breastfeeding period (% Yes)d | 58.8 | 70.6 | .473 |
Distal maternal risk factors | |||
Gravidity at intake | 2.9 (1.5) | 2.2 (1.1) | .064 |
Parity at intake | 2.6 (1.6) | 2.0 (.9) | .093 |
Height at interview (cm) | 157.1 (7.6) | 154.7 (5.5) | .274 |
Weight at interview (kg) | 68.0 (22.0) | 50.4 (11.3) | .004 |
Occipitofrontal circumference at interview (cm) | 56.6 (2.9) | 54.0 (1.7) | .002 |
Upper left arm circumference at interview (cm) | 28.3 (4.8) | 23.9 (3.7) | .004 |
BMI at interview | 27.2 (7.5) | 21.1 (4.6) | .004 |
Age at interview (yrs) | 32.7 (8.1) | 27.4 (5.1) | .019 |
aSpecific alcohol consumption information by trimester was known for n = 19 for women without supplementation and n = 19 for women with supplementation.
bAmong drinkers only.
cBreastfeeding information was known for n = 19 for women without supplementation and n = 20 for women with supplementation.
dAmong those who breastfed.
Table A2.
At 60 months | Alcohol-exposed with MCM not supplemented (n = 19) | Alcohol-exposed with MCM supplemented (n = 19) | p |
---|---|---|---|
Mean (SD) | Mean (SD) | ||
Height centile | 19.4 (25.9) | 24.2 (21.3) | .538 |
Weight centile | 15.4 (23.9) | 19.4 (18.7) | .574 |
OFC centile | 18.8 (17.8) | 23.7 (25.3) | .491 |
OFC ≤ 3rd centile | 21.1 | 26.3 | .703 |
OFC ≤ 10th centile | 47.4 | 31.6 | .319 |
Inner canthal distance (ICD) centile | 62.8 (20.8) | 68.8 (11.0) | .278 |
Inner pupillary distance (IPD) centile | 58.8 (23.2) | 57.4 (22.8) | .845 |
Palpebral fissure length (PFL) centile | 22.6 (18.6) | 21.8 (17.6) | .887 |
Smooth philtrum (% Yes) | 52.6 | 36.8 | .328 |
Narrow vermilion (% Yes) | 31.6 | 52.6 | .189 |
Hypoplastic midface (% Yes) | 63.2 | 47.4 | .328 |
Maxillary arc (in cm) | 23.2 (.8) | 22.8 (.8) | .155 |
Mandibular arc (in cm) | 24.4 (1.0) | 23.8 (.9) | .055 |
Strabismus (% Yes) | 10.5 | 5.3 | .547 |
Epicanthal folds (% Yes) | 57.9 | 68.4 | .501 |
Prognathism (% Yes) | 0.0 | 0.0 | – |
Camptodactyly (% Yes) | 0.0 | 0.0 | – |
Number of minor anomalies | 6.4 (2.8) | 5.9 (2.7) | .598 |
Total dysmorphology score | 11.0 (5.9) | 9.9 (4.9) | .552 |
Table A3.
Alcohol-exposed with MCM not supplemented (n = 15) | Alcohol-exposed with MCM supplemented (n = 17) | p | |
---|---|---|---|
Mean (SD) | Mean (SD) | ||
Cognitive percentile rank at 6 weeksa | 19.9 (14.4) | 22.1 (16.7) | .718 |
Cognitive percentile rank at 9 monthsb | 44.9 (27.0) | 50.8 (23.9) | .461 |
Cognitive percentile rank at 18 monthsc | 24.2 (15.7) | 20.2 (17.0) | .474 |
Cognitive percentile rank at 42 monthsd | 25.8 (13.1) | 32.4 (14.7) | .413 |
Language percentile rank at 6 weeksa | 10.2 (10.5) | 18.5 (16.0) | .132 |
Language percentile rank at 9 monthsb | 20.3 (28.9) | 23.1 (26.2) | .748 |
Language percentile rank at 18 monthsc | 22.9 (19.5) | 22.5 (13.6) | .943 |
Language percentile rank at 42 monthsd | 22.2 (13.3) | 27.9 (17.9) | .542 |
Motor percentile rank at 6 weeksa | 46.0 (20.0) | 32.1 (16.4) | .046 |
Motor percentile rank at 9 monthsb | 36.7 (25.7) | 29.8 (21.3) | .363 |
Motor percentile rank at 18 monthsc | 26.3 (22.7) | 32.1 (16.3) | .391 |
Motor percentile rank at 42 monthsd | 35.0 (28.8) | 62.6 (19.7) | .046 |
Social/emotional percentile rank at 6 weeksa | 38.3 (18.0) | 35.5 (27.5) | .754 |
Social/emotional percentile rank at 9 monthsb | 38.5 (31.7) | 39.9 (32.6) | .892 |
Social/emotional percentile rank at 18 monthsc | 35.2 (27.0) | 34.8 (25.7) | .970 |
Social/emotional percentile rank at 42 monthsd | 36.6 (24.4) | 43.4 (24.0) | .611 |
aN = 11 for not supplemented; N = 22 for supplemented.
bN = 19 for not supplemented; N = 22 for supplemented.
cN = 16 for not supplemented; N = 19 for supplemented.
dN = 5 for not supplemented; N = 10 for supplemented.
Table A4.
Alcohol-exposed with MCM not supplemented (n = 15) | Alcohol-exposed with MCM supplemented (n = 17) | p | |
---|---|---|---|
Mean (SD) | Mean (SD) | ||
Global percentile rank | 9.6 (11.2) | 8.8 (14.0) | .776 |
Sequential short term memory percentile rank | 27.9 (21.3) | 13.8 (16.9) | .036 |
Number recall percentile rank | 52.0 (27.7) | 20.0 (21.3) | <.001 |
Word order recall percentile rank | 14.8 (14.6) | 14.9 (15.6) | .890 |
Simultaneous visual processing percentile rank | 5.0 (8.6) | 5.0 (7.3) | .370 |
Triangles percentile rank | 12.3 (14.0) | 14.6 (19.3) | .887 |
Pattern reasoning percentile rank | 9.8 (12.9) | 14.1 (17.9) | .430 |
Conceptual thinking percentile rank | 12.6 (21.2) | 7.4 (15.0) | .407 |
Long term storage and retrieval percentile rank | 22.4 (15.9) | 27.6 (22.5) | .470 |
Atlantis percentile rank | 29.3 (23.4) | 37.1 (26.1) | .533 |
Rebus percentile rank | 22.9 (21.3) | 22.8 (25.7) | .989 |
Table A5.
Alcohol-exposed with MCM not supplemented (n = 19) N (%) |
Alcohol-exposed with MCM supplemented (n = 22) N (%) |
p-Value from z-test of proportions | |
---|---|---|---|
FAS | 6 (31.6) | 4 (18.2) | .3322 |
PFAS | 3 (15.8) | 5 (22.7) | .5824 |
ARND | 4 (21.1) | 4 (18.2) | .8205 |
ARBD | 0 (0.0) | 1 (4.5) | .3199 |
Not FASD | 6 (31.6) | 8 (36.4) | .7518 |
χ2(4) = 1.977, p = .740.
Funding Statement
Research reported in this publication was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under Award Number R01/U01 AA15134. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Ethical approval
This study adhered to the Declaration of Helsinki. Active consent for all individuals to participate in all phases of this study was obtained from all women and consent for their children from parents. Protocols and consent forms were approved by the University of New Mexico Institutional Review Board, the Stellenbosch University Faculty of Medicine and Health Sciences Ethics Committee, and the University of North Carolina at Chapel Hill.
Author contributions
Philip May was the principal investigator of these NIH-funded FASD epidemiology studies and was the major writer and final editor of all drafts. Anna-Susan Marais served as the overall program manager of all field operations. Ronel Barnard Röhrs was the project coordinator at the intervention site who assisted, supervised, and managed the MCM implementation. Marlene de Vries served as the project coordinator in the control/comparison site and supervised all data collection, protocols, and data quality. Data entry and further data accuracy measures were overseen by the Program Manager, Mrs. Marais, at the main office at the Faculty of Medicine and Health Sciences of Stellenbosch University. Cudore Snell trained all project officers to perform essential case management techniques and supervised them throughout the study. Lise Anthonissen and Erine Bröcker Ritter were the clinical psychologists who performed all neurobehavioral testing of the children at age five. Wendy Kalberg and David Buckley supervised data entry, files, and data sets in the United States, and prepared all data for diagnostic case conferences. Wendy Kalberg supervised the neurobehavioral testing and interpreted the analysis of neurobehavioral results for diagnosis and manuscript preparation. Dixie Hedrick prepared initial drafts of tables and figures. Eugene Hoyme, Luther Robinson, Melanie Manning, and Heidre Bezuidenhout generated final dysmorphology data via individual exams for the team in the field and made the final diagnoses of the children in multidisciplinary case conferences. Soraya Seedat and Charles Parry are the South African co-investigators who participated in the study design, provided oversight, and facilitated all study activities in South Africa, both in the field and at Stellenbosch University, Faculty of Medicine and Health Sciences and the Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council. Each author contributed to the content and empirical evidence of this study, read, edited, and approved various drafts of the manuscript.
Disclosure statement
No potential conflict of interest was reported by the author(s).
References
- 1.Lange S, Probst C, Gmel G, et al. Global prevalence of fetal alcohol spectrum disorder among children and youth: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(10):948–956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Spohr H-L. Fetal alcohol syndrome a lifelong challenge. Berlin/Boston: Walter de Gruyter GmbH; 2018. [Google Scholar]
- 3.Stratton K, Howe C, Battaglia F.. Fetal alcohol syndrome: diagnosis, epidemiology, prevention, and treatment. Washington D.C.: National Academy Press; 1996. [Google Scholar]
- 4.May PA, de Vries MM, Marais AS, et al. The prevalence of fetal alcohol spectrum disorders in rural communities in South Africa: a third regional sample of child characteristics and maternal risk factors. Alcohol Clin Exp Res. 2022;46(10):1819–1836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.May PA, De Vries M, Marais A-S, et al. Replication of high fetal alcohol spectrum disorders prevalence rates, child characteristics, and maternal risk factors in a second sample of rural communities in South Africa. Int J Environ Res Public Health. 2017;14(5):522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.May PA, Marais AS, De Vries MM, et al. The prevalence, child characteristics, and maternal risk factors for the continuum of fetal alcohol spectrum disorders: a sixth population-based study in the same South African community. Drug Alcohol Depend. 2021;218:108408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.May PA, Marais AS, de Vries MM, et al. The continuum of fetal alcohol spectrum disorders in a community in South Africa: prevalence and characteristics in a fifth sample. Drug Alcohol Depend. 2016;168:274–286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.May PA, Chambers CD, Kalberg WO, et al. Prevalence of fetal alcohol spectrum disorders in 4 US communities. J Am Med Assoc. 2018;319(5):474–482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.May PA, Fiorentino D, Coriale G, et al. Prevalence of children with severe fetal alcohol spectrum disorders in communities near Rome, Italy: new estimated rates are higher than previous estimates. Int J Environ Res Public Health. 2011;8(6):2331–2351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.May PA, Fiorentino D, Phillip Gossage J, et al. Epidemiology of FASD in a province in Italy: prevalence and characteristics of children in a random sample of schools. Alcohol Clin Exp Res. 2006;30(9):1562–1575. [DOI] [PubMed] [Google Scholar]
- 11.McCarthy R, Mukherjee R, Fleming AS, et al. Prevalence of fetal alcohol spectrum disorder in greater Manchester, UK: an active case ascertainment study. Alcohol Clin Exp Res. 2021;45(11):2271–2281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Petkovic G, Barisic I.. FAS prevalence in a sample of urban schoolchildren in Croatia. Reprod Toxicol. 2010;29(2):237–241. [DOI] [PubMed] [Google Scholar]
- 13.Petkovic G, Barisic I.. Prevalence of fetal alcohol syndrome and maternal characteristics in a sample of schoolchildren from a rural province of Croatia. Int J Environ Res Public Health. 2013;10(4):1547–1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Popova S, Lange S, Poznyak V, et al. Population-based prevalence of fetal alcohol spectrum disorder in Canada. BMC Public Health. 2019;19(1):845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Olivier L, Urban M, Chersich M, et al. Burden of fetal alcohol syndrome in a rural West Coast area of South Africa. S Afr Med J. 2013;103(6):402–405. [DOI] [PubMed] [Google Scholar]
- 16.Urban MF, Chersich MF, Fourie L-A, et al. Fetal alcohol syndrome among grade 1 schoolchildren in Northern Cape province: prevalence and risk factors. South Afr Med J. 2008;98(11):877–882. [PubMed] [Google Scholar]
- 17.Viljoen DL, Gossage JP, Brooke L, et al. Fetal alcohol syndrome epidemiology in a South African community: a second study of a very high prevalence area. J Stud Alcohol. 2005;66(5):593–604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.National Institute on Alcohol Abuse and Alcoholism . NIAAA Council approves definition of binge drinking. NIAAA Newsletter; 2004. [Google Scholar]
- 19.Livy DJ, Miller EK, Maier SE, et al. Fetal alcohol exposure and temporal vulnerability: effects of binge-like alcohol exposure on the developing rat hippocampus. Neurotoxicol Teratol. 2003;25(4):447–458. [DOI] [PubMed] [Google Scholar]
- 20.May PA, Gossage JP, Marais A-S, et al. Maternal risk factors for fetal alcohol syndrome and partial fetal alcohol syndrome in South Africa: a third study. Alcohol Clin Exp Res. 2008;32(5):738–753. [DOI] [PubMed] [Google Scholar]
- 21.May PA, Hasken JM, Baete A, et al. Fetal alcohol spectrum disorders in a midwestern city: child characteristics, maternal risk traits, and prevalence. Alcohol Clin Exp Res. 2020;44(4):919–938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.May PA, Hasken JM, Bozeman R, et al. Fetal alcohol spectrum disorders in a rocky mountain region city: child characteristics, maternal risk traits, and prevalence. Alcohol Clin Exp Res. 2020;44(4):900–918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.May PA, Hasken JM, Stegall JM, et al. Fetal alcohol spectrum disorders in a southeastern county of the United States: child characteristics and maternal risk traits. Alcohol Clin Exp Res. 2020;44(4):939–959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Popova S, Lange S, Probst C, et al. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(3):e290–e299. [DOI] [PubMed] [Google Scholar]
- 25.Sulik KK, Johnston MC, Webb MA.. Fetal alcohol syndrome: embryogenesis in a mouse model. Science. 1981;214(4523):936–938. [DOI] [PubMed] [Google Scholar]
- 26.Muggli E, O’Leary C, Donath S, et al. "Did you ever drink more?" A detailed description of pregnant women’s drinking patterns. BMC Public Health. 2016;16(1):683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Popova S, Lange S, Probst C, et al. Global prevalence of alcohol use and binge drinking during pregnancy, and fetal alcohol spectrum disorder. Biochem Cell Biol. 2018;96(2):237–240. [DOI] [PubMed] [Google Scholar]
- 28.May PA, Blankenship J, Marais AS, et al. Maternal alcohol consumption producing fetal alcohol spectrum disorders (FASD): quantity, frequency, and timing of drinking. Drug Alcohol Depend. 2013;133(2):502–512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Viljoen D, Croxford J, Gossage JP, et al. Characteristics of mothers of children with fetal alcohol syndrome in the Western Cape province of South Africa: a case control study. J Stud Alcohol. 2002;63(1):6–17. [PubMed] [Google Scholar]
- 30.South African Department of Health , Statistics South Africa , South African Medical Research Council . South Africa demographic and health survey 2016; 2019. [Google Scholar]
- 31.Brun C, Rapp RC.. Strengths-based case management: individuals’ perspectives on strengths and the case manager relationship. Soc Work. 2001;46(3):278–288. [DOI] [PubMed] [Google Scholar]
- 32.Gursansky D, Harvey J, Kennedy R.. Case management policies, practice and professional business. New York, NY: Columbia University Press; 2003. [Google Scholar]
- 33.Miller WR, Rollnick S.. Motivational interviewing: helping people change. 3rd ed. New York, NY: Guilford Press; 2013. [Google Scholar]
- 34.Miller WR, Meyers RJ, Hiller-Sturmhöfel S.. The community-reinforcement approach. In: Psychosocial treatments. New York, NY: Routledge; 2003. [Google Scholar]
- 35.Rapp CA, Goscha RJ.. The principles of effective case management of mental health services. Psychiatr Rehabil J. 2004;27(4):319–333. [DOI] [PubMed] [Google Scholar]
- 36.Timberlake EM, Farber MZ, Sabatino CA.. The general method of social work practice. 4th ed. Boston, MA: Allyn and Bacon; 2002. [Google Scholar]
- 37.Finkelstein N. Treatment issues for alcohol- and drug-dependent pregnant and parenting women. Health Soc Work. 1994;19(1):7–15. [DOI] [PubMed] [Google Scholar]
- 38.McKnight-Eily LR, Okoro CA, Turay K, et al. Screening for alcohol use and brief counseling of adults – 13 states and the District Of Columbia, 2017. MMWR Morb Mortal Wkly Rep. 2020;69(10):265–270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.O’Connor EA, Perdue LA, Senger CA, et al. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: updated evidence report and systematic review for the US preventive services task force. J Am Med Assoc. 2018;320(18):1910–1928. [DOI] [PubMed] [Google Scholar]
- 40.Bakhireva LN, Leeman L, Roberts M, et al. You didn’t drink during pregnancy, did you? Alcohol Clin Exp Res. 2021;45(3):543–547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Fortin M, Muckle G, Jacobson SW, et al. Alcohol use among inuit pregnant women: validity of alcohol ascertainment measures over time. Neurotoxicol Teratol. 2017;64:73–78. [DOI] [PubMed] [Google Scholar]
- 42.Larsson G, Bohlin A.. Fetal alcohol syndrome and preventive strategies. Pediatrician. 1984;14(1–2):51–56. [PubMed] [Google Scholar]
- 43.Schölin L, Fitzgerald N.. The conversation matters: a qualitative study exploring the implementation of alcohol screening and brief interventions in antenatal care in Scotland. BMC Pregnancy Childbirth. 2019;19(1):316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Crawford-Williams F, Steen M, Esterman A, et al. “My midwife said that having a glass of red wine was actually better for the baby”: a focus group study of women and their partner’s knowledge and experiences relating to alcohol consumption in pregnancy. BMC Pregnancy Childbirth. 2015;15(1):79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Greenfield SF, Grella CE.. What is “women-focused” treatment for substance use disorders? Psychiatr Serv. 2009;60(7):880–882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Hesse M, Vanderplasschen W, Rapp R, et al. Case management for persons with substance use disorders. Cochrane Database Syst Rev. 2014;2014(4):CD00265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Joo JY, Huber DL.. Community-based case management effectiveness in populations that abuse substances. Int Nurs Rev. 2015;62(4):536–546. [DOI] [PubMed] [Google Scholar]
- 48.Cheng D, Kettinger L, Uduhiri K, et al. Alcohol consumption during pregnancy: prevalence and provider assessment. Obstet Gynecol. 2011;117(2 Pt 1):212–217. [DOI] [PubMed] [Google Scholar]
- 49.Pazol K, Robbins CL, Black LI, et al. Receipt of selected preventive health services for women and men of reproductive age – United States, 2011–2013. MMWR Surveill Summ. 2017;66(20):1–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Erng MN, Smirnov A, Reid N.. Prevention of alcohol-exposed pregnancies and fetal alcohol spectrum disorder among pregnant and postpartum women: a systematic review. Alcohol Clin Exp Res. 2020;44(12):2431–2448. [DOI] [PubMed] [Google Scholar]
- 51.Handmaker NS, Wilbourne P.. Motivational interventions in prenatal clinics. Alcohol Res Health. 2001;25(3):219–229. [PMC free article] [PubMed] [Google Scholar]
- 52.Hanson JD, Ingersoll K, Pourier S.. Development and implementation of CHOICES group to reduce drinking, improve contraception, and prevent alcohol-exposed pregnancies in American Indian women. J Subst Abuse Treat. 2015;59:45–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.May PA, Miller JH, Goodhart KA, et al. Enhanced case management to prevent fetal alcohol spectrum disorders in Northern plains communities. Matern Child Health J. 2008;12(6):747–759. [DOI] [PubMed] [Google Scholar]
- 54.Montag AC, Dusek ML, Ortega ML, et al. Tailoring an alcohol intervention for American Indian Alaska native women of childbearing age: listening to the community. Alcohol Clin Exp Res. 2017;41(11):1938–1945. [DOI] [PubMed] [Google Scholar]
- 55.Rendall-Mkosi K, Morojele N, London L, et al. A randomized controlled trial of motivational interviewing to prevent risk for an alcohol-exposed pregnancy in the Western Cape, South Africa. Addiction. 2013;108(4):725–732. [DOI] [PubMed] [Google Scholar]
- 56.Meyers RJ, Smith JE.. The community reinforcement approach. New York, NY: Guilford Press; 1995. [Google Scholar]
- 57.May PA, Marais A-S, Gossage JP, et al. Case management reduces drinking during pregnancy among high risk women. Int J Alcohol Drug Res. 2013;2(3):61–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.de Vries MM, Joubert B, Cloete M, et al. Indicated prevention of fetal alcohol spectrum disorders in South Africa: effectiveness of case management. Int J Environ Res Public Health. 2015;13(1):ijerph13010076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Bad Heart Bull L, Kvigne VL, Leonardson GR, et al. Validation of a self-administered questionnaire to screen for prenatal alcohol use in Northern plains Indian women. Am J Prev Med. 1999;16(3):240–243. [PubMed] [Google Scholar]
- 60.Babor TF, de la Fuente JR, Saunders J, et al. AUDIT: the Alcohol Use Disorders Identification Test: guidelines for use in primary health care; 2004. [Google Scholar]
- 61.May PA, Tabachnick BG, Gossage JP, et al. Maternal factors predicting cognitive and behavioral characteristics of children with fetal alcohol spectrum disorders. J Dev Behav Pediatr. 2013;34(5):314–325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Hasken JM, Adair LS, Martin SL, et al. Current research in toxicology the influence of maternal weight and alcohol exposure on infant physical characteristics and neurodevelopmental outcomes. Curr Res Toxicol. 2022;3:100076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.May PA, Gossage JP, Brooke LE, et al. Maternal risk factors for fetal alcohol syndrome in the Western Cape province of South Africa: a population-based study. Am J Public Health. 2005;95(7):1190–1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Bayley N. Bayley scales of infant and toddler development. 3rd ed. New York, NY: Pearson Publishers; 2006. [Google Scholar]
- 65.Kalberg WO, May PA, Buckley D, et al. Early-life predictors of fetal alcohol spectrum disorders. Pediatrics. 2019;144(6):e20182141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Gomez DA, May PA, Tabachnick BG, et al. Ocular measurements in fetal alcohol spectrum disorders. Am J Med Genet A. 2020;182(10):2243–2252. [DOI] [PubMed] [Google Scholar]
- 67.Hoyme HE, Kalberg WO, Elliott AJ, et al. Updated clinical guidelines for diagnosing fetal alcohol spectrum disorders. Pediatrics. 2016;138(2):e20154256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Kaufman A, Kaufman N.. Kaufman assessment battery for children. New York, NY: Pearson Assessment; 2004. [Google Scholar]
- 69.Bangirana P, Musisi S, Allebeck P, et al. A preliminary investigation of the construct validity of the KABC-II in Ugandan children with prior cerebral insult. Afr Health Sci. 2009;9(3):186–192. [PMC free article] [PubMed] [Google Scholar]
- 70.Skuy M, Taylor M, O’Carroll S, et al. Performance of black and white South African children on the Wechsler Intelligence Scale for children-revised and the Kaufman Assessment Battery. Psychological Reports. 2000;86(3 Pt 1):727–737. [DOI] [PubMed] [Google Scholar]
- 71.Hoyme HE, May PA, Kalberg WO, et al. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 institute of medicine criteria. Pediatrics. 2005;115(1):39–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.IBM. IBM SPSS statistics for windows; 2021. [Google Scholar]
- 73.Roozen S, Peters G-JY, Kok G, et al. Worldwide prevalence of fetal alcohol spectrum disorders: a systematic literature review including meta-analysis. Alcohol Clin Exp Res. 2016;40(1):18–32. [DOI] [PubMed] [Google Scholar]
- 74.Prochaska JO, DiClemente CC.. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390–395. [DOI] [PubMed] [Google Scholar]
- 75.Prochaska JO, Diclemente CC, Norcross JC.. In search of how people change: applications to addictive behaviors. J Addict Nurs. 1993;47(9):1102–1114. [DOI] [PubMed] [Google Scholar]
- 76.Young JK, Giesbrecht HE, Eskin MN, et al. Nutrition implications for fetal alcohol spectrum disorder. Adv Nutr. 2014;5(6):675–692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.May PA, Hamrick KJ, Corbin KD, et al. Maternal nutritional status as a contributing factor for the risk of fetal alcohol spectrum disorders. Reprod Toxicol. 2016;59:101–108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.May PA, Hamrick KJ, Corbin KD, et al. Dietary intake, nutrition, and fetal alcohol spectrum disorders in the Western Cape province of South Africa. Reprod Toxicol. 2014;46:31–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.May PA, de Vries MM, Marais AS, et al. The continuum of fetal alcohol spectrum disorders in four rural communities in South Africa: prevalence and characteristics. Drug Alcohol Depend. 2016;159:207–218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Carter RC, Georgieff MK, Ennis KM, et al. Prenatal alcohol-related alterations in maternal, placental, neonatal, and infant iron homeostasis. Am J Clin Nutr. 2021;114(3):1107–1122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Jacobson SW, Hoyme HE, Carter RC, et al. Evolution of the physical phenotype of fetal alcohol spectrum disorders from childhood through adolescence. Alcohol Clin Exp Res. 2021;45(2):395–408. [DOI] [PubMed] [Google Scholar]
- 82.Carter RC, Jacobson JL, Sokol RJ, et al. Fetal alcohol-related growth restriction from birth through young adulthood and moderating effects of maternal prepregnancy weight. Alcohol Clin Exp Res. 2013;37(3):452–462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Carter RC, Senekal M, Dodge NC, et al. Maternal alcohol use and nutrition during pregnancy: diet and anthropometry. Alcohol Clin Exp Res. 2017;41(12):2114–2127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Bagnato SJ, Goins DD, Pretti-Frontczak K, et al. Authentic assessment as “best practice” for early childhood intervention. Top Early Child Spec Educ. 2014;34(2):116–127. [Google Scholar]
- 85.Riley K, Miller G, Sorenson C.. Early childhood authentic and performance-based assessment. In: Garro A, editor. Early childhood assessment in school and clinical child psychology. New York, NY: Springer; 2016. p. 95–117. [Google Scholar]
- 86.May PA, Hasken JM, Blankenship J, et al. Breastfeeding and maternal alcohol use: prevalence and effects on child outcomes and fetal alcohol spectrum disorders. Reprod Toxicol. 2016;63:13–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Abell K, May W, May PA, et al. Fetal alcohol spectrum disorders and assessment of maxillary and mandibular arc measurements. Am J Med Genet A. 2016;170(7):1763–1771. [DOI] [PubMed] [Google Scholar]
- 88.Valentine M, Bihm DCJ, Wolf L, et al. Computer-aided recognition of facial attributes for fetal alcohol spectrum disorders. Pediatrics. 2017;140(6):e20162028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Lagadec N, Steinecker M, Kapassi A, et al. Factors influencing the quality of life of pregnant women: a systematic review. BMC Pregnancy Childbirth. 2018;18(1):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Adebiyi BO, Mukumbang FC, Beytell AM.. A guideline for the prevention and management of fetal alcohol spectrum disorder in South Africa. BMC Health Serv Res. 2019;19(1):1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Adebiyi BO, Mukumbang FC, Beytell AM.. To what extent is fetal alcohol spectrum disorder considered in policy-related documents in South Africa? A document review. Health Res Policy Syst. 2019;17(1):1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Adebiyi BO, Mukumbang FC, Beytell AM.. Policy requirements for the prevention and management of fetal alcohol spectrum disorder in South Africa: a policy brief. Front Public Health. 2021;9(April):592726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Adebiyi BO, Mukumbang FC, Cloete LG, et al. Exploring service providers’ perspectives on the prevention and management of fetal alcohol spectrum disorders in South Africa: a qualitative study. BMC Public Health. 2018;18(1):1–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Adebiyi BO, Mukumbang FC, Okop KJ, et al. A modified Delphi study towards developing a guideline to inform policy on fetal alcohol spectrum disorders in South Africa: a study protocol. BMJ Open. 2018;8(4):e019907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Jacobs L, Steyn N, Labadarios D.. 2013. ‘Mind the gap’: observations in the absence of guidelines for alcohol abstinence among expectant women in South Africa. Available from: https://repository.hsrc.ac.za/bitstream/handle/20.500.11910/3008/7682.pdf?sequence=1
- 96.Foroud T, Wetherill L, Vinci-Booher S, et al. Relation over time between facial measurements and cognitive outcomes in fetal alcohol-exposed children. Alcohol Clin Exp Res. 2012;36(9):1634–1646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Hankin J, Mccaul ME, Heussner J.. Pregnant, alcohol-abusing women. Alcohol Clin Exp Res. 2000;24(8):1276–1286. [PubMed] [Google Scholar]
- 98.May PA, Hasken JM, De Vries MM, et al. A utilitarian comparison of two alcohol use biomarkers with self-reported drinking history collected in antenatal clinics. Reprod Toxicol. 2018;77:25–32. [DOI] [PMC free article] [PubMed] [Google Scholar]